iiinova — where your digital self keeps evolving

Reposted by Vikram M. Narayan, MD

David Y.T. Chen @dytcmd.bsky.social · 12/07/2026

Proud of our SUO fellowship alums, congrats @ssjoshi.bsky.social! The latest of many grads from our program to be recognized for their outstanding teaching skills www.foxchase.org/current-fell... #SurgEd

foxchase.org

Current Fellows and Alumni - Urology | Fox Chase Cancer Center - Philadelphia PA

AUA 2025 Las Vegas, NV Current Fellows

031

Vikram M. Narayan, MD @drnarayan.com · 28/06/2026

Congratulations to Nick Eyrich, Talia Helman, Davis Kim, and Nelson Kuete on their graduation from #EmoryUrology residency - we are so proud of all of you and it has been an honor to see you grow into the wonderful physicians that you are

000

Vikram M. Narayan, MD @drnarayan.com · 28/06/2026

Congrats to my friend @ssjoshi.bsky.social for winning the 2026 Resident Teaching Award!! Couldn’t go to a better person!

010

Vikram M. Narayan, MD @drnarayan.com · 28/06/2026

Congratulations to @tgoodstein.bsky.social on her graduation from SUO Fellowship. We are proud of being able to always call you our first fellow! @emoryuroonc.bsky.social @ssjoshi.bsky.social @valentinagrajales.bsky.social

131

Vikram M. Narayan, MD @drnarayan.com · 26/05/2026

Proud of my Informatics and Radiology colleague Elias Kikano who helped spearhead the validation effort and for continuing to help @emoryhealthcareatl.bsky.social lead the way

120

Vikram M. Narayan, MD @drnarayan.com · 04/11/2025

Join us for our SUO Fellowship Virtual Open House on January 13, 2026, 7-8 PM EST @ssjoshi.bsky.social @emoryuroonc.bsky.social . Register here: zoom.us/meeting/regi...

031

Reposted by Vikram M. Narayan, MD

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · 17/07/2025

Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF

163

Vikram M. Narayan, MD @drnarayan.com · 08/06/2025

Thanks to Zachary Klaassen for a great conversation on BCG unresponsive non-muscle invasive #bladdercancer —working through three common, real-world patient cases to think through practical considerations on sequencing and using these new therapies. www.urotoday.com/video-lectur...

urotoday.com

Nadofaragene Firadenovec for BCG-Unresponsive CIS: Efficacy, Durability, and Practical Considerations - Vikram Narayan

Zachary Klaassen speaks with Vikram Narayan from Emory University about nadofaragene firadenovec, a first-in-class gene therapy for BCG-unresponsive bladder cancer. Dr. Narayan explains how this non-r...

140

Reposted by Vikram M. Narayan, MD

American Journal of Kidney Diseases @ajkd.bsky.social · 07/06/2025

#Quiz A 61-year-old woman presented with refractory hypercalcemia. She had obstructive uropathy secondary to bilateral ureteral stones. The stone composition was 80% calcium oxalate, 20% calcium phosphate. What was the etiology? bit.ly/Varanasi25Quiz (FREE)

011

Vikram M. Narayan, MD @drnarayan.com · 03/06/2025

My takeaways: -Well done study with 1000+ randomized, credit to the authors + participants - Still a hard sell for NMIBC—AE risks warrant close collab w/ med onc despite likely push to do these in the urology clinics “bc it’s subQ” -If you don’t have BCG, you still don’t have BCG—and this needs BCG

000

Vikram M. Narayan, MD @drnarayan.com · 03/06/2025

Results of CREST: sasanlimab+BCG in BCG naive HR NMIBC patients offers a 32% risk reduction in HR recurrence, persistent CIS, progression, or death compared to BCG alone. www.nature.com/articles/s41... AEs are 🤨 - Grade 3 - 29%(!!) for sasanlimab pts vs 6% for BCG - 2 treatment related deaths

nature.com

110

Reposted by Vikram M. Narayan, MD

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · 31/05/2025

Radiation oncologist Patricia Santos, MD, MS, @trishasantos.bsky.social shares insights on her poster highlighting “Access to cancer care for undocumented immigrants in the United States.” #ASCO25

031

Reposted by Vikram M. Narayan, MD

Emory Urologic Oncology @emoryuroonc.bsky.social · 30/04/2025

Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com

022

Vikram M. Narayan, MD @drnarayan.com · 29/04/2025

Congratulations to Sid Marthi @emoryuroonc.bsky.social for winning Best Poster at this morning’s Improving Access & Outcomes Across All Populations session at #AUA2025, highlighting the great collaboration between #GradyHealth, #MorehouseSM and #Emory to improve #ProstateCancer care inequities

142

Vikram M. Narayan, MD @drnarayan.com · 29/04/2025

Kudos to @amehtamd.bsky.social and colleagues for a fantastic session on vasectomy guidelines - key takeaways: fascial interposition, allow patient autonomy, and there’s no plausible biological link to prostate cancer #AUA2025

130

Reposted by Vikram M. Narayan, MD

innocent4real.bsky.social @innocent4real.bsky.social · 28/04/2025

A good #AUA2025. Thank you for the invitation to present on the topic of APPs in leadership! #APPSession #Urology

011

Vikram M. Narayan, MD @drnarayan.com · 26/04/2025

Enjoying a sparks flying crossfire in treatment BCG unresponsive NMIBC, special shout out to my partner @ssjoshi.bsky.social and my friends Vig Packiam, Cheryl Lee, William Huang, and @tullikagarg.bsky.social at #AUA2025

064

Vikram M. Narayan, MD @drnarayan.com · 24/03/2025

My sincere thanks to Philipp Dahm, the University of #Minnesota Department of Urology, and the Minnesota #Urologic Society for the honor of a VP invitation—was great to see and spend time with old friends and mentors

150

Vikram M. Narayan, MD @drnarayan.com · 01/02/2025

Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial

181

Reposted by Vikram M. Narayan, MD

Valentina Grajales MD MS @valentinagrajales.bsky.social · 25/01/2025

“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology” @emoryuroonc.bsky.social

094

Vikram M. Narayan, MD @drnarayan.com · 12/01/2025

Looking forward to this! DM me if interested

010

Reposted by Vikram M. Narayan, MD

Emory Urologic Oncology @emoryuroonc.bsky.social · 12/01/2025

Interested in learning about Emory’s #SUO fellowship? 📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social

053

Reposted by Vikram M. Narayan, MD

The BMJ @bmj.com · 31/12/2024

Surgeons showed significantly greater manual dexterity compared with physicians, nurses, and non-clinical staff when assessed using a buzz wire game. But had the highest rates of swearing www.bmj.com/content/387/...

39335

Vikram M. Narayan, MD @drnarayan.com · 20/12/2024

Thx again to my friend @ddshapiro.bsky.social for giving us an outstanding Grand Rounds today @emoryuroonc.bsky.social & @winshipatemory.bsky.social on #RenalMedullaryCarcinoma. Inspiring work presented in an incredibly understandable & engaging way @msaouel.bsky.social @jackiebrownmd.bsky.social

194

Reposted by Vikram M. Narayan, MD

Eric Umbreit @umbreit.bsky.social · 06/12/2024

Happy to meet with anyone interested in the @SUO Fellowship @uthealthsa.bsky.social 🔬 Robust research opportunities 🎓 Master's Degree ✂️ High surgical volume in open and robotic approaches Send me a DM if interested #SUO24

051

Reposted by Vikram M. Narayan, MD

Justin R. Gregg, MD @justinrgregg.bsky.social · 04/12/2024

(1/8) For those on Bluesky, I'm a uro onc @mdanderson.bsky.social specializing in prostate cancer, biomarkers, disparities, and behavioral interventions. We're taking a tour through classic obesity literature to help inform patient counseling and future studies.

142

Reposted by Vikram M. Narayan, MD

Shreyas Joshi, MD @ssjoshi.bsky.social · 05/12/2024

Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants? @valentinagrajales.bsky.social

093

Reposted by Vikram M. Narayan, MD

Dan Shapiro, MD @ddshapiro.bsky.social · 05/12/2024

Proud of my friend @drnarayan.com giving great talk at #suo on cystectomy for NMIBC

0111

Reposted by Vikram M. Narayan, MD

Justin R. Gregg, MD @justinrgregg.bsky.social · 04/12/2024

What better time than #SUO24 to jump over to Bluesky! Thanks @chapinmd.bsky.social and @drnarayan.com for the nudge. Stay tuned, I'll be sure to keep the prostate cancer/obesity threads going over here.

0143

Vikram M. Narayan, MD @drnarayan.com · 01/12/2024

Looking forward to #SUO24 in a few days And my friend @jackiebrownmd.bsky.social’s presentation on Emerging Perioperative Systemic Therapy for Urothelial Cancer at this year’s #BladderCancer course @winshipatemory.bsky.social @emoryuroonc.bsky.social

0112

Vikram M. Narayan, MD @drnarayan.com · 28/11/2024

Happy #Thanksgiving to all of my wonderful friends and colleagues Switching over to #Claude by @anthropic.com today from #ChatGPT (we had a fight) and trying to convince myself I don’t need this puppy www.casio.com/us/watches/c...

030

Reposted by Vikram M. Narayan, MD

Shreyas Joshi, MD @ssjoshi.bsky.social · 27/11/2024

Urology residents of @bsky.app , let us know if you will be in Dallas for SUO 2024 and would like to chat about the @emoryuroonc.bsky.social SUO Fellowship! @drnarayan.com @valentinagrajales.bsky.social

063

Vikram M. Narayan, MD @drnarayan.com · 27/11/2024

Interesting study…only 56% OS at 5 years strikes me as lower than I would expect; by comparison an 80% 5 year OS was observed in the ph3 nado trial for BCG unresponsive pts (76% in CIS only patients, 86% in papillary dz). Worth calling out the 53% grade 3 AE rate as well… @emoryuroonc.bsky.social

031

Reposted by Vikram M. Narayan, MD

Shreyas Joshi, MD @ssjoshi.bsky.social · 25/11/2024

@emoryuroonc.bsky.social welcome to Bluesky!

033

Vikram M. Narayan, MD @drnarayan.com · 25/11/2024

Welcome to @bsky.app my friend @ddshapiro.bsky.social Time to get him added to the GU onc and kidney cancer starter packs!! bsky.app/start/did:pl...

0135

Reposted by Vikram M. Narayan, MD

Dieter Bohn @backlon.com · 23/11/2024

My best travel tip is to quickly say "have a nice day" to the driver dropping you off so as to avoid spending the entire trip thinking about you said "you too" in response to "have a nice flight."

71884